BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15063097)

  • 1. Phylogenomic and chemotaxonomic analysis of the endocannabinoid system.
    McPartland JM
    Brain Res Brain Res Rev; 2004 Apr; 45(1):18-29. PubMed ID: 15063097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala.
    Gulyas AI; Cravatt BF; Bracey MH; Dinh TP; Piomelli D; Boscia F; Freund TF
    Eur J Neurosci; 2004 Jul; 20(2):441-58. PubMed ID: 15233753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors.
    Saario SM; Laitinen JT
    Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):287-93. PubMed ID: 17910610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coevolution between cannabinoid receptors and endocannabinoid ligands.
    McPartland JM; Norris RW; Kilpatrick CW
    Gene; 2007 Aug; 397(1-2):126-35. PubMed ID: 17537592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocannabinoid chemical biology: a tool for the development of novel therapies.
    Petrosino S; Ligresti A; Di Marzo V
    Curr Opin Chem Biol; 2009 Jun; 13(3):309-20. PubMed ID: 19457702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling.
    Egertová M; Cravatt BF; Elphick MR
    Neuroscience; 2003; 119(2):481-96. PubMed ID: 12770562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrolysis of prostaglandin glycerol esters by the endocannabinoid-hydrolyzing enzymes, monoacylglycerol lipase and fatty acid amide hydrolase.
    Vila A; Rosengarth A; Piomelli D; Cravatt B; Marnett LJ
    Biochemistry; 2007 Aug; 46(33):9578-85. PubMed ID: 17649977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system.
    Fezza F; De Simone C; Amadio D; Maccarrone M
    Subcell Biochem; 2008; 49():101-32. PubMed ID: 18751909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
    Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
    Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid receptors: where they are and what they do.
    Mackie K
    J Neuroendocrinol; 2008 May; 20 Suppl 1():10-4. PubMed ID: 18426493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological tools in endocannabinoid neurobiology.
    Mor M; Lodola A
    Curr Top Behav Neurosci; 2009; 1():87-110. PubMed ID: 21104381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple roles for the endocannabinoid system during the earliest stages of life: pre- and postnatal development.
    Fride E
    J Neuroendocrinol; 2008 May; 20 Suppl 1():75-81. PubMed ID: 18426504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?
    Oesch S; Gertsch J
    J Pharm Pharmacol; 2009 Jul; 61(7):839-53. PubMed ID: 19589225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the endocannabinoid-degrading enzyme fatty acid amide hydrolase by follicle-stimulating hormone.
    Grimaldi P; Rossi G; Catanzaro G; Maccarrone M
    Vitam Horm; 2009; 81():231-61. PubMed ID: 19647115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
    Ligresti A; Petrosino S; Di Marzo V
    Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel natural and synthetic ligands of the endocannabinoid system.
    Hanus LO; Mechoulam R
    Curr Med Chem; 2010; 17(14):1341-59. PubMed ID: 20166928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolutionary origins of the endocannabinoid system.
    McPartland JM; Matias I; Di Marzo V; Glass M
    Gene; 2006 Mar; 370():64-74. PubMed ID: 16434153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of the endocannabinoid system in obesity.
    Engeli S
    J Neuroendocrinol; 2008 May; 20 Suppl 1():110-5. PubMed ID: 18426509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of receptors for endocannabinoids in human and rodent skeletal muscle.
    Cavuoto P; McAinch AJ; Hatzinikolas G; Janovská A; Game P; Wittert GA
    Biochem Biophys Res Commun; 2007 Dec; 364(1):105-10. PubMed ID: 17935697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a short-term exposure to alcohol in rats on FAAH enzyme and CB1 receptor in different brain areas.
    Rubio M; de Miguel R; Fernández-Ruiz J; Gutiérrez-López D; Carai MA; Ramos JA
    Drug Alcohol Depend; 2009 Jan; 99(1-3):354-8. PubMed ID: 18922654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.